FDA strengthened alli Drug Facts in June 2026 after rare kidney complications.
SAFETY FIRST / 2026 LABELS
Orlistat safety: read the current warnings.
A nonprescription label is still a medicine label. Orlistat can cause gastrointestinal effects, reduce absorption of some nutrients, interact with other therapies and—rarely—be associated with serious kidney or liver problems. These concerns belong in the buying decision, not in fine print after checkout.
This page summarizes official U.S. references for alli 60 mg and prescription Xenical 120 mg, including FDA’s June 10, 2026 kidney-safety communication. It does not diagnose symptoms or replace individual medical advice.
FDA June 2026 updateOTC and Rx distinctionsInteraction awareness
Advertising disclosure: partner buttons lead to an independent third-party provider. Orlivexa does not sell, prescribe or dispense medication.
● 60 mg OTC vs 120 mg Rx● Current FDA label warnings● Independent, no live inventory claims
BUYER BASICS
Start with the right distinction.
Each part of this guide addresses a different shopping or safety decision. Read the product label and confirm the real merchant’s terms before acting.
Oily spotting, loose stool and urgency are listed risks associated with fat malabsorption.
Medication review can matter for thyroid, transplant, blood-thinning and seizure therapies.
01 / JUNE 2026 FDA UPDATE
Rare kidney injuries changed the OTC label
FDA approved revised alli 60 mg Drug Facts to warn about rare acute kidney injury, kidney stones and related oxalate complications. People who have ever had kidney disease or kidney stones are advised to ask a healthcare provider before use. The agency describes risk reports involving both OTC and prescription-strength orlistat.
Symptoms named in the communication include severe pain in the back or groin, painful urination, blood in the urine, swelling of feet or legs and urinating less often than normal. FDA instructs consumers who develop such symptoms to stop using alli and consult a clinician. Do not assume this warning is irrelevant because the product is available in a retail aisle.
Independent partner link; product and eligibility details are determined by the external provider.
02 / GASTROINTESTINAL EFFECTS
Digestive changes are expected risks, not marketing trivia
Orlistat acts in the intestine to reduce absorption of some dietary fat. That mechanism can lead to oily spotting, loose or fatty stool, gas with discharge, urgency and more frequent bowel movements. The OTC Drug Facts notes that a lower-fat diet can reduce these effects; a product offer that omits them is not giving a complete picture.
Severe or persistent abdominal pain deserves clinical attention rather than trial-and-error dose changes. Orlistat should not be seen as permission to disregard dietary advice. The 60 mg label overview explains what to look for in the product leaflet.
03 / MEDICINES AND VITAMINS
Some combinations require professional review
The alli label warns consumers not to use it while taking cyclosporine and to ask a professional about anticoagulants, amiodarone, diabetes therapies, thyroid medicines, seizure treatments, antiretrovirals and other weight-loss products. The current Xenical prescribing information gives additional monitoring and administration instructions for interacting medicines.
Orlistat can reduce absorption of fat-soluble vitamins, so product labels discuss separating a multivitamin from orlistat. Those details are not a reason to improvise timing for a complex medication list: ask a pharmacist who can review all drugs and supplements together.
Independent partner link; product and eligibility details are determined by the external provider.
04 / LIVER, PREGNANCY AND OTHER RISKS
Look beyond the kidney headline
The OTC label tells consumers to stop use and ask a doctor about signs such as yellowing of the skin or eyes, dark urine, loss of appetite or severe continuous abdominal pain. It also says not to use the product during pregnancy or breastfeeding, and flags an organ-transplant history and malabsorption conditions.
The updated Xenical prescription label has its own contraindications and a pregnancy discussion. Do not copy contraindication lists from an old blog or assume the 60 mg Drug Facts can be applied word-for-word to prescription 120 mg. A clinician should evaluate which warnings apply to the individual patient.
05 / TURN WARNINGS INTO A BUYING CHECK
A safer checkout begins before the order
Read the complete label associated with the exact product, identify who is selling or dispensing it and understand how to reach a pharmacist or clinician. If an ad promises guaranteed weight loss, says there are “no side effects” or treats prescription 120 mg as an unrestricted OTC product, those are reasons to distrust the offer.
Use our seller verification checklist before payment, or review the difference between orlistat and alli. For unexplained symptoms or complex conditions, prioritize care over price shopping.
NO INVENTED PRICES · NO FAKE PHARMACIES
Keep product identity ahead of the sale.
An outside seller sets the final price and eligibility conditions. Use your own label and pharmacy checks before you decide.
COMMON QUESTIONS
Answers without the hype.
Did the FDA change the Alli label in 2026?
Yes. On June 10, 2026, FDA announced strengthened warnings about rare kidney injury and kidney stones with OTC alli 60 mg.
Can orlistat affect vitamin absorption?
Yes. The labeling discusses reduced absorption of certain fat-soluble vitamins and use of a multivitamin. Follow the exact label and consult a pharmacist for personal medication questions.
Is orlistat appropriate during pregnancy?
The OTC alli label says not to use during pregnancy or breastfeeding. Prescription Xenical has its own current pregnancy section and must be discussed with a clinician.
Does OTC status mean orlistat is free of serious risks?
No. The Drug Facts includes important warnings, and FDA has described rare serious kidney complications.
Referral link only. No claim of pharmacy verification, stock or savings.
Primary sources
These independent government and DailyMed sources support the material above. They do not endorse this site or any merchant.
THE BOTTOM LINE
Compare clearly. Choose carefully.
Check formulation, regulatory status, real seller information and current warnings before completing a purchase decision.